News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

06

2023

-

05

News | Linuo Pharmaceutical and Beijing Nuokangda Pharmaceutical signed a strategic entrusted research and development framework agreement

Classification:

Corporate News


On May 5, the signing ceremony of the strategic entrusted research and development framework agreement between Shandong Linuo Pharmaceutical Co., Ltd. (hereinafter referred to as Linuo Pharmaceutical) and Beijing Nuokangda Pharmaceutical Technology Co., Ltd. Headquarters held. Chen Peng, Chairman of Nuokangda Pharmaceuticals, Tao Xiumei, General Manager, Gao Yuankun, Chairman and President of Linuo Group, Lun Lijun, Chairman of Keyuan Pharmaceuticals and Linuo Pharmaceuticals, Jiang Hongsheng, General Manager of Linuo Pharmaceuticals, attended the signing ceremony.

11

Before the signing ceremony, Gao Yuankun and his entourage visited Nuokangda’s nearly 40,000 square meters R&D office park to learn more about Nuokangda Pharmaceutical’s R&D process management model, daily work style and agile and efficient execution.

Chairman Gao Yuankun highly recognized the R&D strength, management system and cultural construction of Nuokangda Pharmaceuticals. Mr. Gao believes that Linuo Pharmaceutical and Nuokangda Pharmaceutical have a high degree of fit in terms of corporate culture and management philosophy. Manufacturing advantages can be combined quickly and form complementary advantages.

11

Linuo Pharmaceutical is a high-tech new chemical drug manufacturing enterprise integrating R&D, production and sales. Adhering to the corporate mission of "Healthy China Commitment", it gives full play to the synergistic advantages of the integration of raw materials and preparations, and is committed to becoming a first-class chemical company in China. Pharmaceutical manufacturing service provider. The research and development advantage of Nuo Kangda Pharmaceuticals is to provide full-chain R&D services based on excipient research and preparation technology as the core. At present, 108 approval documents have been obtained for partners.

After exchanges, based on the principles of friendly negotiation and mutual benefit, the two parties signed a strategic entrusted research and development framework agreement. In the future, the two parties will carry out strategic cooperation in the fields of improved preparations, high-end generic drugs, special medical food, medical aesthetics and high value-added innovative excipients, and work together to achieve better development in the overall situation of high-quality development.

11

Related news

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

2023-08-31

On August 29, the "Central Media High-Quality Development Theme Communication Activity" participated by more than ten media including People's Daily, Xinhua News Agency, Guangming Daily, etc., visited Shandong Keyuan Pharmaceutical Co., Ltd.

Solidly promote the

Solidly promote the "Quality Month" activities to help quality work reach a new level | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a Quality Month Knowledge Competition!

2023-08-30

Quality is the core competitiveness related to the survival of an enterprise. Strengthening the construction of a quality enterprise is an effective measure for Keyuan Pharmaceutical (stock code: 301281.SZ) to implement the concept of "lean production and quality first". The company continues to improve the quality system and strengthen training.

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

2023-08-24

In order to thoroughly implement the theme spirit of "Quality is in my hands and customers are in my heart" for Keyuan Pharmaceutical (stock code: 301281.SZ) Quality Month in 2023, and empower and improve quality management, the Quality Management Center and Human Resources Center held a meeting on August 23 The joint organization carried out a one-day QC group activity training meeting.

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

2023-08-23

In order to better carry forward the corporate culture spirit of family, one table meal, one heart, one effort, enhance the cohesion and sense of belonging of all employees, enrich the spiritual and cultural life of employees, and let the majority of employees feel that Keyuan Pharmaceutical (stock code: 301281.SZ) The warmth of the big family.